Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for Insulin Resistance in Burn Patients
NCT00732485Phase 3Withdrawn
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Aug 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in burn injury comparing Fenofibrate with Placebo (2 arms). Primary endpoint: Insulin sensitivity on glucose and protein metabolism at 6 months. Planned start Aug 2008; status: withdrawn.
02
Drugs
fenofibrate
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00732485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732485.